The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer

Background/Aims This study was conducted to identify prognostic factors in patients with papillary thyroid cancer (PTC) at the time of first radioactive iodine (RAI) therapy, and to evaluate the clinical value of the thyroglobulin (Tg) increase after RAI. Methods Serum Tg was sampled prior to (pre-T...

Full description

Bibliographic Details
Main Authors:	Hee Kyung Kim, Jee Hee Yoon, Jin Seong Cho, Seong Young Kwon, Su Woong Yoo, Ho-Cheol Kang
Format:	Article
Language:	English
Published:	The Korean Association of Internal Medicine 2020-09-01
Series:	The Korean Journal of Internal Medicine
Subjects:	thyroid cancer, papillary radioactive iodine therapy thyroglobulin prognosis therapeutic response
Online Access:	http://www.kjim.org/upload/pdf/kjim-2018-173.pdf

Similar Items

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
by: Zhichao Xing, et al.
Published: (2021-01-01)

Stimulated serum thyroglobulin levels versus unstimulated serum thyroglobulin in the follow-up of patients with papillary thyroid carcinoma
by: Saumya Sara Sunny, et al.
Published: (2018-01-01)

Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
by: Su Woong Yoo, et al.
Published: (2020-01-01)

Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer
by: Leonardo Bandeira, et al.

Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
by: Zhong-Ling Qiu, et al.
Published: (2020-01-01)

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
by: Tang J, et al.
Published: (2018-06-01)

Preablative Stimulated Thyroglobulin and Thyroglobulin Reduction Index as Decision-Making Markers for Second Radioactive Iodine Therapy in Patients with Structural Incomplete Response
by: Wang L, et al.
Published: (2021-07-01)

Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
by: Jonghwa Ahn, et al.
Published: (2020-03-01)

Added Value of Thyroglobulin Measurement in the Fine-Needle Aspiration Washout to Diagnose Cervical Metastatic Lymphadenopathy from Papillary Thyroid Cancer
by: Lan Yun, et al.
Published: (2016-11-01)

Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
by: Yuchen Jin, et al.
Published: (2017-11-01)

Papillary Thyroid Carcinoma Formation In A Thyroglossal Cyst: A Case Report
by: Hashmi H, et al.
Published: (2007-01-01)

Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma
by: Huan Zhao, et al.
Published: (2017-04-01)

Ultrasonography, Cytology, and Thyroglobulin Measurement Results of Cervical Nodal Metastasis in Patients With Unclear Papillary Thyroid Carcinoma
by: Jong Heon Lim, et al.
Published: (2019-06-01)

Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study
by: Xiaomeng Jia, et al.
Published: (2020-07-01)

Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma
by: Congcong Wang, et al.
Published: (2021-05-01)

Lateral neck multilevel fine‐needle aspiration cytology and thyroglobulin estimation in papillary thyroid carcinoma
by: Yuntao Song, et al.
Published: (2021-06-01)

Clinical significance of thyroglobulin autoantibodies enhancement in patients with differentiated thyroid cancer after thyroidectomy and radioiodine therapy
Published: (2013-09-01)

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer
by: Szabina Szujo, et al.
Published: (2021-01-01)

Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma
by: M. Cecilia Martins-Costa, et al.
Published: (2017-02-01)

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
by: Jonghwa Ahn, et al.
Published: (2020-12-01)

CYTOLOGICAL CHARACTERISTICS OF POSTOPERATIVE METASTASES OF PAPILLARY THYROID CANCER DURING THE DEVELOPMENT OF SECONDARY RADIOIODINE REFRACTORINESS
by: Anna Zelinskaya, et al.
Published: (2020-01-01)

Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma
by: Eun Ji Oh, et al.
Published: (2020-05-01)

Cervical lymphatic malformation demonstrating thyroglobulin on fine needle aspirate washout
by: Ashwin Agnihotri, et al.
Published: (2020-12-01)

Radioiodine therapy in skeletal metastases from well-differentiated thyroid cancer: a Johannesburg experience
by: Nalini Sindy Perumal, et al.
Published: (2010-03-01)

Intraoperative measurement of thyroglobulin in lymph node aspirates for the detection of metastatic papillary thyroid carcinoma
by: Wang Y, et al.
Published: (2017-09-01)

The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: A retrospective cohort study and systematic review of the literature
by: Evangelos Karvounis, et al.
Published: (2021-01-01)

A Role for Iodide and Thyroglobulin in Modulating the Function of Human Immune Cells
by: Mahmood Y. Bilal, et al.
Published: (2017-11-01)

Pre-Ablation Thyroglobulin Levels and Persistence / Recurrence Associated to Early Differentiated Thyroid Cancer
by: Arturo Mejía López, et al.
Published: (2014-01-01)

A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [<sup>18</sup>F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer
by: Hong Hua Piao, et al.
Published: (2021-05-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

POSTRADIAL SIALOZOADENITIS IN PATIENTS WITH PAPILLARY CARCINOMA OF THE THYROID GLAND
by: V. A. Kovalenko, et al.
Published: (2015-02-01)

Synergic radiosensitization of sinomenine hydrochloride and radioiodine on human papillary thyroid carcinoma cells
by: Aomei Zhao, et al.
Published: (2021-10-01)

Significance of Thyroglobulin in Thyroid Diseases Detected by the Immunoperoxidase Method
by: Paisal Parichatikanond, et al.
Published: (2020-08-01)

Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
by: Pedro Weslley Rosario, et al.

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up
by: Abdul K. Siraj, et al.
Published: (2020-12-01)

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
by: Mohamed Aashiq, et al.
Published: (2019-09-01)

The Role of Intraoperative Thyroglobuline Level of Lymph Node in the Management of Papillary Thyroid Cancer (Determination of a Cutoff Point)
by: Mohsen Kolahdouzan, et al.
Published: (2017-01-01)

Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study
by: Kyungsik Kim, et al.
Published: (2021-08-01)

Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?
by: Justin Benjamin, et al.
Published: (2019-01-01)